We have good news: One of our top lobbyists just confirmed that members of Congress are hopeful about their negotiations on an upcoming legislative package that could expand access to quality, affordable health care.
Proposed regulation could put cancer therapies out of reach for patients on Medicare Part D plans
The administration has proposed a policy change to Medicare Part D that could have devastating consequences for cancer patients on Medicare.
These proposed changes could have wide-ranging impact as currently 43 million American seniors rely on Medicare Part D plans for their prescription drug coverage.
The proposed changes could allow the plans to:
- Delay patient access to cutting edge cancer drugs
- Overrule oncologists and deny coverage for a drug a doctor recommends
Cancer patients enrolled in Medicare Part D plans could be negatively affected by this proposed policy change as they could be denied coverage for lifesaving drugs.
Join us in asking Congress and the administration to protect cancer patients by stopping this proposed regulation. We must do all we can to make prescription drugs more accessible and affordable for cancer patients.